PL2646015T3 - Aktywny enancjomer 2-(n,n-dimetyloamino)-propionianu dodecylu - Google Patents
Aktywny enancjomer 2-(n,n-dimetyloamino)-propionianu dodecyluInfo
- Publication number
- PL2646015T3 PL2646015T3 PL11845087T PL11845087T PL2646015T3 PL 2646015 T3 PL2646015 T3 PL 2646015T3 PL 11845087 T PL11845087 T PL 11845087T PL 11845087 T PL11845087 T PL 11845087T PL 2646015 T3 PL2646015 T3 PL 2646015T3
- Authority
- PL
- Poland
- Prior art keywords
- dimethylamino
- propionate
- dodecyl
- active enantiomer
- enantiomer
- Prior art date
Links
- HSMMSDWNEJLVRY-INIZCTEOSA-N dodecyl (2s)-2-(dimethylamino)propanoate Chemical compound CCCCCCCCCCCCOC(=O)[C@H](C)N(C)C HSMMSDWNEJLVRY-INIZCTEOSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41899610P | 2010-12-02 | 2010-12-02 | |
| PCT/US2011/062579 WO2012075107A2 (en) | 2010-12-02 | 2011-11-30 | Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate |
| EP11845087.3A EP2646015B1 (en) | 2010-12-02 | 2011-11-30 | Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2646015T3 true PL2646015T3 (pl) | 2020-11-30 |
Family
ID=46172526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11845087T PL2646015T3 (pl) | 2010-12-02 | 2011-11-30 | Aktywny enancjomer 2-(n,n-dimetyloamino)-propionianu dodecylu |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20130267562A1 (pl) |
| EP (1) | EP2646015B1 (pl) |
| JP (1) | JP6109075B2 (pl) |
| KR (1) | KR102004552B1 (pl) |
| CN (1) | CN103930105B (pl) |
| AU (2) | AU2011336692B2 (pl) |
| BR (1) | BR112013012799A8 (pl) |
| CA (1) | CA2817417C (pl) |
| CL (1) | CL2013001391A1 (pl) |
| CR (1) | CR20130324A (pl) |
| ES (1) | ES2801999T3 (pl) |
| IL (1) | IL226173A (pl) |
| MX (1) | MX2013005522A (pl) |
| NZ (1) | NZ609826A (pl) |
| PL (1) | PL2646015T3 (pl) |
| RU (1) | RU2679308C2 (pl) |
| SG (2) | SG190199A1 (pl) |
| WO (1) | WO2012075107A2 (pl) |
| ZA (1) | ZA201304840B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014028780A2 (en) * | 2012-08-15 | 2014-02-20 | Nexmed Holdings, Inc. | Antifungal compounds and methods of use |
| US8900625B2 (en) | 2012-12-15 | 2014-12-02 | Nexmed Holdings, Inc. | Antimicrobial compounds and methods of use |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6118020A (en) * | 1999-05-19 | 2000-09-12 | Nexmed Holdings, Inc. | Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate |
| US6323241B1 (en) * | 2000-01-10 | 2001-11-27 | Nexmed (Holdings) Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| KR20050045946A (ko) * | 2002-06-25 | 2005-05-17 | 애크럭스 디디에스 피티와이 리미티드 | 비정질 약학적 조성물을 이용한 경피전달속도의 제어 |
| US20050181030A1 (en) * | 2003-01-03 | 2005-08-18 | Mo Y. J. | Topical stabilized prostaglandin E compound dosage forms |
| PL2106805T3 (pl) * | 2003-03-21 | 2011-10-31 | Nexmed Holdings Inc | Przeciwgrzybicza powłoka na paznokcie |
| US20070269379A1 (en) * | 2003-07-23 | 2007-11-22 | Samir Mitragotri | Penetration Enhancer Combinations for Transdermal Delivery |
| BRPI0414551B8 (pt) * | 2003-10-10 | 2021-05-25 | Antares Pharma Ipl Ag | formulação farmacêutica transdérmica ou transmucosa e método de protelação ou inibição da cristalização de um agente ativo |
| US20050113274A1 (en) * | 2003-11-22 | 2005-05-26 | Nadir Buyuktimkin | Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents |
| MX2012012824A (es) * | 2010-05-04 | 2013-07-03 | Nexmed Holdings Inc | Composiciones de productos terapeuticos de moleculas pequeñas. |
| US8900625B2 (en) * | 2012-12-15 | 2014-12-02 | Nexmed Holdings, Inc. | Antimicrobial compounds and methods of use |
-
2011
- 2011-11-30 US US13/991,111 patent/US20130267562A1/en not_active Abandoned
- 2011-11-30 SG SG2013035258A patent/SG190199A1/en unknown
- 2011-11-30 AU AU2011336692A patent/AU2011336692B2/en not_active Ceased
- 2011-11-30 NZ NZ609826A patent/NZ609826A/en not_active IP Right Cessation
- 2011-11-30 CN CN201180054224.5A patent/CN103930105B/zh not_active Expired - Fee Related
- 2011-11-30 BR BR112013012799A patent/BR112013012799A8/pt not_active Application Discontinuation
- 2011-11-30 JP JP2013542128A patent/JP6109075B2/ja not_active Expired - Fee Related
- 2011-11-30 ES ES11845087T patent/ES2801999T3/es active Active
- 2011-11-30 RU RU2013119439A patent/RU2679308C2/ru not_active Application Discontinuation
- 2011-11-30 SG SG10201803321TA patent/SG10201803321TA/en unknown
- 2011-11-30 WO PCT/US2011/062579 patent/WO2012075107A2/en active Application Filing
- 2011-11-30 EP EP11845087.3A patent/EP2646015B1/en active Active
- 2011-11-30 CA CA2817417A patent/CA2817417C/en not_active Expired - Fee Related
- 2011-11-30 PL PL11845087T patent/PL2646015T3/pl unknown
- 2011-11-30 KR KR1020137013227A patent/KR102004552B1/ko active IP Right Grant
- 2011-11-30 MX MX2013005522A patent/MX2013005522A/es unknown
-
2013
- 2013-05-05 IL IL226173A patent/IL226173A/en active IP Right Grant
- 2013-05-16 CL CL2013001391A patent/CL2013001391A1/es unknown
- 2013-06-26 CR CR20130324A patent/CR20130324A/es unknown
- 2013-06-28 ZA ZA2013/04840A patent/ZA201304840B/en unknown
-
2017
- 2017-01-17 AU AU2017200314A patent/AU2017200314A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2817417C (en) | 2020-12-29 |
| AU2011336692A1 (en) | 2013-05-30 |
| JP6109075B2 (ja) | 2017-04-05 |
| EP2646015A2 (en) | 2013-10-09 |
| EP2646015A4 (en) | 2015-04-08 |
| CN103930105B (zh) | 2019-11-01 |
| SG190199A1 (en) | 2013-06-28 |
| CA2817417A1 (en) | 2012-06-07 |
| WO2012075107A2 (en) | 2012-06-07 |
| NZ609826A (en) | 2016-03-31 |
| BR112013012799A8 (pt) | 2018-01-09 |
| CN103930105A (zh) | 2014-07-16 |
| MX2013005522A (es) | 2013-07-17 |
| IL226173A0 (en) | 2013-07-31 |
| ZA201304840B (en) | 2014-04-30 |
| BR112013012799A2 (pt) | 2016-09-13 |
| AU2017200314A1 (en) | 2017-02-02 |
| IL226173A (en) | 2016-10-31 |
| EP2646015B1 (en) | 2020-04-22 |
| JP2014514243A (ja) | 2014-06-19 |
| RU2013119439A (ru) | 2015-01-10 |
| SG10201803321TA (en) | 2018-06-28 |
| CR20130324A (es) | 2013-08-13 |
| KR102004552B1 (ko) | 2019-10-01 |
| AU2011336692B2 (en) | 2017-02-16 |
| ES2801999T3 (es) | 2021-01-15 |
| RU2679308C2 (ru) | 2019-02-07 |
| CL2013001391A1 (es) | 2013-11-08 |
| WO2012075107A3 (en) | 2014-03-06 |
| US20130267562A1 (en) | 2013-10-10 |
| KR20140023875A (ko) | 2014-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20182039T1 (hr) | NOVE STRUKTURNO DIZAJNIRANE MOLEKULE shRNA | |
| EP2561892A4 (en) | SOLID PREPARATION EASILY ADMINISTRABLE | |
| GB2478954B (en) | Active target | |
| EP2716402A4 (en) | ACTIVE METAL BRAZING MATERIAL | |
| HRP20150230T1 (en) | New application forms for cineol | |
| EP2583349A4 (en) | ACTIVE CIRCULATOR | |
| EP2864328B8 (en) | Pharmaceutically active compounds | |
| ZA201207458B (en) | Deodorant composition comprising violet nitrile | |
| EP2564852A4 (en) | MEDICAMENT TREATING CEREBRAL TUMORS | |
| ZA201304840B (en) | Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate | |
| HK1191942A1 (zh) | 新型六氫環戊二烯並吡咯酮，六氫吡咯並吡咯酮，八氫吡咯並吡啶酮和八氫吡啶酮化合物 | |
| ZA201207398B (en) | Non-enteric pharmaceutical composition comprising crofelemer | |
| HRP20160687T1 (hr) | Supstituirani 2-(kroman-6-iloksi)tiazoli i njihova upotreba kao farmaceutska sredstva | |
| IL231096A0 (en) | 2-converted thiazoles (chroman-6-yloxy) and their use as pharmaceutical preparations | |
| GB201015203D0 (en) | Active enantiomer | |
| TWM433307U (en) | Outer package re-use type triangle desk calendar | |
| AU2011900015A0 (en) | Novel Antisense Oligonucleotides | |
| AU2011901336A0 (en) | Active Castor | |
| TWM386787U (en) | Perfume rings | |
| GB201016061D0 (en) | Tipit portion dispenser | |
| PL390718A1 (pl) | Taczka |